The Global Positive Airway Pressure Devices is anticipated to grow at a tremendous CAGR of 8.40% and will reach USD 3.12 billion during the forecast period from 2021 to 2026. As per DelveInsight Analysis in the Positive Airway Pressure Devices market, the growing number of patients suffering from obstructive sleep apnea, rising prevalence of chronic respiratory diseases, the entrance of key PAP devices companies such as LivaNova, ResMed, Koninklijke Philips N.V., along with the rising awareness regarding the benefits of positive airway pressure therapy is expected to drive the Positive Airway Pressure Devices market growth and increment in patients for their treatment options.
DelveInsight’s Positive Airway Pressure Devices Market Insights and Forecast provides the current and forecasted Positive Airway Pressure Devices Market forecasts for the next five years, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Positive Airway Pressure Devices Market.
Positive Airway Pressure Devices Overview
Positive Airway Pressure (PAP) therapy is widely used in the treatment of obstructive sleep apnea and snoring. The Positive Airway Pressure devices are also used in the respiratory ventilation for improvising oxygenation of patients in intensive care units (ICUs). PAP machine includes straps for positioning the mask, a hose or tube to connect the mask to a motor, and an air filter for purifying the entry of air entering the nose and mouth. Nowadays, automatic positive airway pressure devices rely on proprietary algorithms to adjust the pressure delivered noninvasively are gaining traction worldwide for obstructive sleep apnea treatment at home.
Overall PAP therapy is a safe and effective treatment, however, there are a few counter-indications. Positive Airway Pressure devices therapy is a prescribed treatment as the air pressure required for stabilizing the airway, also known as the therapeutic pressure is different for every individual.
Positive Airway Pressure Devices Market Insights
Geographically, the global Positive Airway Pressure Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the Global PAP devices market and is expected that it will remain constant during the forecast period. This domination is attributed to certain factors such as the growing demand because of the high prevalence of obstructive sleep apnea, rising prevalence of respiratory disorders like asthma, COPD, rising product launch, and well-established reimbursement scenario in the region among other factors in the region. All these factors combined are anticipated to bolster the market for Positive Airway Pressure Devices.
Furthermore, the prompt and well-established healthcare services and infrastructure contributes to the growth of the regional Positive Airway Pressure devices market growth. Also, the presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for the Positive Airway Pressure Devices market.
In addition to that, the presence of key players in the Asia-Pacific region and an increase in cases of obstructive sleep apnea may lead to an increase in demand observed for the Positive Airway Pressure Devices market. Also, the rising geriatric population in the region has a higher susceptibility to respiratory disorders, along with rising healthcare costs, improving healthcare infrastructure population, and growing healthcare expenditure is further projected to augment the Positive Airway Pressure Devices market in the region.
To know more about why North America is leading the market growth in the Positive Airway Pressure Devices market, get a snapshot of the report Positive Airway Pressure Devices Market Report
Latest Updates In Positive Airway Pressure Devices Market
- On September 16, 2021, ResMed had launched the AirSense 11 PAP Series, the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea.
- On June 15, 2021, LivaNova had received FDA approval for a clinical study to evaluate the aura6000 System for the treatment of Obstructive Sleep Apnea.
- In June 2021, Philips Respironics voluntarily recalled certain ventilators, bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP), and continuous positive airway pressure (CPAP) machines due to potential health risks.
Interested in knowing how the Positive Airway Pressure Devices Market will be growing by 2026? Click to get a snapshot of Positive Airway Pressure Devices Recent Updates
Key Players Proactively Working In the Positive Airway Pressure Devices Market
Key Positive Airway Pressure Devices companies contribute a lot to the development of these devices, they are also involved in mergers and acquisitions to strengthen their market position. Some of the key Positive Airway Pressure companies operating actively in the market include Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited., APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Löwenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Löwenstein Medical Technology GmbH + Co. KG and others.
COVID-19 Impact On Positive Airway Pressure Devices Market
The COVID-19 pandemic had a profound impact on elective and non-urgent surgeries across the countries. The demand for Positive Airway Pressure Devices is primarily affected by the outbreak of the COVID-19 pandemic. The government imposed lockdowns to curb the spread of the virus leading to restrictions in movement and a decrease in regular check-ups. Owing to the COVID-19 pandemic situation, various forms of elective procedures were temporarily stopped in contrast to the COVID-19 affected patients that were given utmost priority. This led to a decrease in the surgery required for Positive Airway Pressure Devices. However, decreasing the number of cases, increasing vaccination number, and relief in lockdowns are expected to boost the demand for Positive Airway Pressure Devices.
However, post-COVID-19 the healthcare system is trying to get normalcy owing to the resumed patent visits, the opening of manufacturing facilities, leverage given in terms of lockdown restrictions among others. Hence, the demand for Positive Airway Pressure Devices is expected to rise in the market in the post-pandemic scenario during the forecast period.
To discuss more regarding the short/long-term impact of COVID-19 get a snapshot of the report Positive Airway Pressure Devices COVID-19 Assessment
Scope of the Positive Airway Pressure Devices Market Report:
- Geography Covered: Global
- Study Period: 2021-2026
- Market Segmentation By Device Type: CPAP machine (continuous positive airway pressure), BiPAP machine (bi-level positive airway pressure), APAP machine (automatic positive airway pressure), others
- Market Segmentation By Age Group: Adults, Pediatrics
- Market Segmentation By End Use: Hospitals, Clinics, Homecare Settings
- Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
- Positive Airway Pressure Devices Companies in the Market: ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, APEX MEDICAL CORP, ARMSTRONG MEDICAL (an EAKIN Company), Smiths Medical, Compumedics Limited, VYAIRE MEDICAL, INC., Somnera Inc, 3B Medical Inc, DeVilbiss Healthcare LLC, Curative Medical Inc, Somnetics International, Inc, Löwenstein Medical UK Ltd., Beijing Aeonmed Co., Ltd., medin Medical Innovations GmbH, medicraft, Hebei Topson Medical Technology Ltd., Sefam, Löwenstein Medical Technology GmbH + Co. KG and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The Positive Airway Pressure Devices market is expected to grow at a CAGR of 8.40% during the forecast period from 2021 to 2026 to reach USD 3.12 billion by 2026.
Table of Contents
| 1 | Report Introduction |
| 2 | Executive Summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Positive Airway Pressure Devices Market Key Factors Analysis |
| 5 | Positive Airway Pressure Devices Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Positive Airway Pressure Devices Market |
| 7 | Positive Airway Pressure Devices Market Layout |
| 8 | Positive Airway Pressure Devices Global Company Share Analysis – Key 3-5 Companies |
| 9 | Positive Airway Pressure Devices Companies and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
To get a deeper understanding of key companies related to the Positive Airway Pressure Devices Market, get a snapshot of the Positive Airway Pressure Devices Market Landscape
Key Takeaways From the Positive Airway Pressure Devices Market Report Study
- Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
- The effect of the COVID-19 pandemic on this Positive Airway Pressure Devices market.
- Top key product/services/technology developments, mergers, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Positive Airway Pressure Devices Market.
- Various opportunities are available for the other competitor in the Positive Airway Pressure Devices Market space.
- Which are the regions and countries where companies should have concentrated on opportunities for Positive Airway Pressure Devices market growth in the coming future?
Learn More About DelveInsight Report Offerings
Chronic Obstructive Pulmonary Disease (COPD) Market
DelveInsight’s, “Chronic Obstructive Pulmonary Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products, and key Chronic Obstructive Pulmonary Disease companies involved like GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A, United Therapeutics Corporation, Verona Pharma plc, AstraZeneca, Immunotek, Novartis, Genentech, Vertex Pharmaceuticals, Glenmark Pharmaceuticals, EmeraMed, Afimmune, 3SBio, OmniSpirant, Rhizen Pharmaceuticals, Foresee Pharmaceuticals, Brickell Biotech and many more.
DelveInsight’s ‘Pulse Oximeters – Market Insights, Competitive Landscape and Market Forecast – 2026’ report delivers an in-depth understanding of Pulse Oximeters, historical and forecasted Pulse Oximeters market trends, market drivers, market barriers and key Pulse Oximeters companies involved like Medtronic, Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation. Meditech Equipment Co ., Ltd, and several others.
DelveInsight’s Airway Stent – Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of the market and Competitive Landscape analysis. Key Airway stents companies involved in this market include Boston Medical Products, TAEWOONG Medical Co., Boston Scientific Corporation, Novatech SA, among others
Artificial Lung Devices Pipeline
DelveInsight’s, “Artificial Lung Devices–Pipeline Insight and Competitive Landscape, 2021,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the artificial lung devices pipeline landscape which includes key artificial lung devices companies like Lung Biotechnology, Miromatrix, Charles Stark Draper Laboratory Inc, United Therapeutics Corporation, XVIVO Perfusion, Medtronic, Getinge, Xenios AG, ALung Technologies Inc., MC3 Cardiopulmonary, Abiomed and many more.
DelveInsight’s ‘Cough Assist Devices – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, market drivers & barriers, unmet needs and key Cough Assist Devices companies involved such as Koninklijke Philips N.V, Percussionaire Corp., Emerson, Hill Rom, Dima Italia SRL, and many more.
Acute Respiratory Distress Syndrome Pipeline
DelveInsight’s, “Acute Respiratory Distress Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+ pipeline drugs in the Acute Respiratory Distress Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key Acute Respiratory Distress Syndrome companies involved like Faron Pharmaceuticals, BioMarck Pharmaceuticals, Athersys, Apeiron Biologics, Cynata Therapeutics, Orbsen Therapeutics, GEn1E Lifesciences, Exvastat, Longeveron, CohBar, ZyVersa Therapeutics, Abbreos, Aviceda Therapeutics, ImStem Biotechnology, Bayer and many more.
Interstitial Lung Diseases Pipeline
DelveInsight’s, “Interstitial Lung Diseases – Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key Interstitial Lung Disease companies involved like AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, Bellerophon Pulse Technologies, OncoArendi Therapeutics, LTT Bio-Pharma, EmphyCorp, Genentech, Blade Therapeutics, Acceleron Pharma and many more.
Browse Through Our Blog Posts
- Alarming Growth of Chronic Respiratory Diseases and Their Prolonged Impact on the Quality of Life
- Asthma: Rising Prevalence And The Key Challenges In The Management
- Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Us
Shruti Thakur
+1(919)321-6187